| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |